Sublingual Semaglutide (generic Ozempic®) now available! Get Started
Dashboard
Compound Catalog

Tolterodine Tartrate

Tolterodine Tartrate is a potent antimuscarinic agent primarily used to manage symptoms associated with overactive bladder, such as urinary frequency, urgency, and incontinence. By selectively targeting muscarinic receptors in the bladder, it helps reduce involuntary bladder contractions, thereby improving bladder control and patient quality of life.

Its efficacy and safety profile make it a preferred choice for healthcare providers seeking to tailor treatment plans for patients with urinary disorders. Tolterodine Tartrate is often utilized in compounded formulations to meet specific patient needs, offering flexibility in dosage and administration.

Trusted by 60,357 patients to date.
A group of faces of our past satisfied patients.
A svg symbol of a mortar and pestle with ingredients going in.
Custom made in our compounding labs.
Sliders that show the customization of ingredients.
Personalized treatment for better results.
User with a gear showing the personalization of the formulation.
All strengths and ingredients are tailored to your needs.
This medication is not available at retail pharmacies. It is compounded, and may be more effective at treating you or your patient.
This is some text inside of a div block.
Loading icon rotating.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Active Ingredient Information

A small arrow pointing down

Tolterodine Tartrate is a potent antimuscarinic agent widely used in the management of overactive bladder (OAB) symptoms, including urinary frequency, urgency, and incontinence. By selectively targeting muscarinic receptors in the bladder, Tolterodine Tartrate effectively reduces involuntary detrusor muscle contractions, thereby improving bladder control and patient quality of life.

Its pharmacological action is primarily attributed to its ability to inhibit acetylcholine binding, which is crucial in the contraction of bladder smooth muscle. This mechanism of action makes Tolterodine Tartrate a preferred choice for patients who require a tailored approach to managing OAB symptoms, especially when standard treatments are insufficient or contraindicated.

In clinical practice, Tolterodine Tartrate is often favored for its favorable side effect profile compared to other anticholinergic agents. It is metabolized in the liver, primarily by the cytochrome P450 enzyme CYP2D6, and its pharmacokinetics can vary based on genetic polymorphisms affecting this enzyme.

Prescribers should consider potential drug interactions and the patient's metabolic profile when recommending Tolterodine Tartrate, ensuring optimal therapeutic outcomes. Its use in compounded formulations allows for customized dosing and delivery methods, enhancing patient adherence and treatment efficacy.

Formulas using

Tolterodine Tartrate

Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.